NCAM1 and liver cancer: The levels of the active NK cells (CD56+CD161+), the activated NK cells (CD56+CD314+), and the inactive NK cells (CD56+CD158+) from the peripheral blood of the patients with liver cancer, liver cirrhosis, and chronic hepatitis were regarded as the major detection indices and comparatively analyzed in detail.